Menu

Impact Events

More
Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
4/19/18 Eli Lilly (LLY) Baricitinib for Rheumatoid Arthritis (RA) Subscribers Only Subscribers Only Subscribers Only
4/19/18 Polyphor POL6326 for Breast Cancer Subscribers Only Subscribers Only Subscribers Only
4/18/18 AstraZeneca (AZN) Tagrisso for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only
4/18/18 Calithera Biosciences (CALA) CB-839 for Renal Cell Cancer (RCC) Subscribers Only Subscribers Only Subscribers Only
4/18/18 Solid Biosciences (SLDB) SGT-001 for Duchenne Muscular Dystrophy (DMD) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected
Date Range
Lead
Company
Drug Expected
Catalyst
04/19/18 Subscribers Only Subscribers Only Regulatory - FDA Advisory Panel Meeting
04/19/18 Subscribers Only Subscribers Only Regulatory - FDA Advisory Panel Meeting
04/19/18 Subscribers Only Subscribers Only Company - Analyst/R&D Update
04/19/18 Subscribers Only Subscribers Only Company - Analyst/R&D Update
04/19/18 Subscribers Only Subscribers Only Trial Data - Updated Results
Back to the top Back to the top